{"name":"Outcomes'10","slug":"outcomes-10","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"High-flow medical oxygen insufflation","genericName":"High-flow medical oxygen insufflation","slug":"high-flow-medical-oxygen-insufflation","indication":"Acute hypoxemic respiratory failure","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Low-flow medical oxygen insufflation","genericName":"Low-flow medical oxygen insufflation","slug":"low-flow-medical-oxygen-insufflation","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"High-flow medical oxygen insufflation","genericName":"High-flow medical oxygen insufflation","slug":"high-flow-medical-oxygen-insufflation","phase":"marketed","mechanism":"High-flow medical oxygen insufflation delivers oxygen at elevated flow rates to improve tissue oxygenation and support respiratory function.","indications":["Acute hypoxemic respiratory failure","Severe hypoxemia requiring high-flow oxygen support"],"catalyst":""},{"name":"Low-flow medical oxygen insufflation","genericName":"Low-flow medical oxygen insufflation","slug":"low-flow-medical-oxygen-insufflation","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPR3dueExBdFNyQlprR2RqZUNhRlhvbGtMYU1CNU9obzFLcmpLTWo5WWdUSzhOMEczd2xLMVhCZDhiUzVyMGl6VmxMVUZDTjJnVkVGWnhiTFJyVW1SV0tzY19RUDRGcnBUZGdaeHVJM2NkRFV1dHJ2a3k5RFFpb3JKZlVNRXg1NXdOV01MaEpzd0tsQTVLd2NCWTh4MXhpNXNSN0RsT295LUxkVE16OXlWMmpyeXVlalVxUUVPZklB?oc=5","date":"2026-03-05","type":"pipeline","source":"Stock Titan","summary":"Experimental anxiety drug helps 67% of hard-to-treat patients - Stock Titan","headline":"Experimental anxiety drug helps 67% of hard-to-treat patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQZmsyVU0xYlVyZVA5dTZydWtvVjFpSHhOVkt3Yk90WHpZXzZ3ZEdsVXpZc0lVMlBEdjlTbXBMWGNQRG1GQVRGMThQa3QyZ09WelBRUnVST1YyamhJeUZrNWhrZHMwQzBwMmF0SFdVNmx5VG5yaDV1eWVOWlcyYThQLTYxRU4tcmRVNU9TRlJQWUFwWjNuVkRyOWNLNk90NEhhQlkwVDNqbjU4bUJXUWtELWs4M3JlTnIybC03QmpNZWNiOG8?oc=5","date":"2026-02-05","type":"earnings","source":"Arrowhead Pharmaceuticals, Inc.","summary":"Arrowhead Pharmaceuticals Reports Fiscal 2026 First Quarter Results - Arrowhead Pharmaceuticals, Inc.","headline":"Arrowhead Pharmaceuticals Reports Fiscal 2026 First Quarter Results - Arrowhead Pharmaceuticals, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNRDQ4UzEwRUNfY1pNeVZtLTA4V0VjRU1FdEhBanREc3BvOWEtcFdHWEhtSjNfcmZUd1oxbXRWOHpoYVJZLWxYb3Fldk9WWFJocVJVVkFFdzF3TV8wajY4ZlJSNDItWjNKWkp3Nkg4cjdjdXdDUTI3LWF1YUdyMkV0YjZFdjlZOVZXSGJSczhTRDczZE1lM3BBQ24zT3E3TTE2R1JLc1BaX0tlXzdBVlM0R1J2cUI?oc=5","date":"2026-02-04","type":"earnings","source":"ig.com","summary":"AstraZeneca Full-Year 2025 Earnings Preview: 10 February 2026 - ig.com","headline":"AstraZeneca Full-Year 2025 Earnings Preview: 10 February 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNazh2WTVKU1lfWmVSNjRONVFmTUh1TDZycU5CSGU0Q3ZCSW4yM0VONjktemk2QlRhdFFPaUFFdW5zQjZXWmxNaFcySlFTc05DRFVQcjg2b1pyYk1EbG92cDZWTXNkalJENGZ1bnRGTl9jUDBJMFVXa2hrbllyTkoxQ05HUEswZUtXNk16TmhvNWJvdG1RWXVINQ?oc=5","date":"2026-01-09","type":"pipeline","source":"pwc.com","summary":"Future of Pharma: Breakthroughs at Scale - pwc.com","headline":"Future of Pharma: Breakthroughs at Scale","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQeEtzWkwyOTd2aXpBWVdib2xLT0F0bnlMNkRXWXFBd0tPaHcwZlFPU2VpWkRJWjNwanZ5WVVyTFJDNWlTSm9XSWhUSVg4TkVTZ1RkeGROQXZ6TEFCdHRKcUZuLVNWbjhKS3VQRlFndUFkT09LTW83b3BpbG1qRXVKVktZZllDbXZyNTRURQ?oc=5","date":"2026-01-05","type":"trial","source":"BioPharma Dive","summary":"10 clinical trials to watch in the first half of 2026 - BioPharma Dive","headline":"10 clinical trials to watch in the first half of 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxONXo1NzZKdVNuVnh3N0hzc0RBSUFacUU2OF9rNm5PRFpQSVJpc1FQVHhURzN1RzZuaFJXN1BWTjNKVmVvQ0dGM3RGUWdnbjgzRlZGYmxXbkJRd1A0X1ZtYy1nUGx2VEc3Wk9LRzlKcTF5TDJIdXdZb2lLQ0tBRExFSVJlbDN5Zw?oc=5","date":"2025-12-16","type":"pipeline","source":"statnews.com","summary":"We crunched the numbers on drug discovery in the U.S. vs. China. The results were alarming - statnews.com","headline":"We crunched the numbers on drug discovery in the U.S. vs. China. The results were alarming","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwJBVV95cUxPNTBhcjJWOTMySVZTX01MMHhUMkRxNkhia3hIWUp3UnJwbFJwekQ1bTNySkZEWm5DQXo2eXRZekRDNWxoblU2ckVyNVl5QVltWVl5QzFtbzREVjJ4ZE1LeXh6SzBmY1VkS2xiQWRLSGxHXzBQdjZ5azVHRnZudElJellBSFpPVnZmX1pyVHFmQ0NCdndRWEJjY2tZMU00WWhya1BqcHRuOU51RXNQT1VEdnpDX1FUZTBrVEdhakNMM0VsZjQ4WEEtT1JIeGFFcTNPZ1NLX1ZhSVVhWjVsR0U1NTZIQ0g2bUx0YVZYWVNvSi1hb2U2RGo5M3FXME5qVGltaXhCbnRoNHVESnhlMGM1RkU3dw?oc=5","date":"2025-11-10","type":"earnings","source":"GlobeNewswire","summary":"ARS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights for neffy® (epinephrine nasal spray) - GlobeNewswire","headline":"ARS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights for neffy® (epinephrine nasal spray)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-24","type":"pipeline","source":"ET Pharma","summary":"Over 70% of digital projects in Pharma fail to deliver intended outcomes: Vector analysis - ET Pharma","headline":"Over 70% of digital projects in Pharma fail to deliver intended outcomes: Vector analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTFBNRTRnMUIwOUxkNWhSeXc3aWtHdTFVZjZhdEZ2WDdaVE9ZS3VlaEl6c201Zml6UnpjTHhXOTk1WkJLQmFzQWRDcUtGTDVjcTFBRXZ2NWY4ZERrLVZUUm15bDR3TVhVMnFEdDVvWU82bw?oc=5","date":"2025-10-07","type":"pipeline","source":"PharmaLive","summary":"The 2025 Outcomes Creativity Index - PharmaLive","headline":"The 2025 Outcomes Creativity Index","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNSV80b1dBaWRZLVNDUDRBeG9XSzJWT0xyTHdMbXZ0VnllOXdCWFRDUFR2TTRXY002eUNzemZYY3RFTUt2b3dDeW92S0ZucTZ3aHNlblZkeERKcUIxQzJxWXZFb3JzcVdJLWhCOTFrN05IbFBnWXRvQW9KVHpwZDlvSExuNnJFVGdEWlFFX2ZxRWFsVjc4YVk1U2ln?oc=5","date":"2025-09-18","type":"trial","source":"Yahoo Finance","summary":"Lipella Pharmaceuticals Announces Positive Final Results from Phase 2a Study of LP-10 in Oral Lichen Planus - Yahoo Finance","headline":"Lipella Pharmaceuticals Announces Positive Final Results from Phase 2a Study of LP-10 in Oral Lichen Planus","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2025-08-10","type":"pipeline","source":"simplywall.st","summary":"Results: Avadel Pharmaceuticals plc Exceeded Expectations And The Consensus Has Updated Its Estimates - simplywall.st","headline":"Results: Avadel Pharmaceuticals plc Exceeded Expectations And The Consensus Has Updated Its Estimates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxORDBEMDAyQ0tqX2NrLUd3Y1RrRlBybXJTSzhUZ25vTmFHN0Fhbk1yQk9YVlJMQnIzem9CZ0lwckhyZUQ5azV5dTdOMTNaN2JTeXZRUnZ4ZEFJTWQ1UVFkblVZREtTTzdqckppUU53bk5wZEFJdEszZkFaQ0NKS3RpYUowX2g1VU5ibWNaNTE2dDhIS0hfX0VQVnZ3dFgyUkdsSWVSaWZ4ckM5cUNvUFRoUzhvejhnd0F5Qi05UjU2bw?oc=5","date":"2025-05-07","type":"earnings","source":"prnewswire.com","summary":"Vanda Pharmaceuticals Reports First Quarter 2025 Financial Results - prnewswire.com","headline":"Vanda Pharmaceuticals Reports First Quarter 2025 Financial Results","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}